register for a free guide

Subscribe via email today


16
Jul

Qnexa, one of the three latest prescription weight loss drugs to be submitted to the FDA has been rejected by the U.S. Food and Drug Administration advisers.

The health advisors expressed concerns about this new once-a-day pill because of risks of it leading to depression, memory-loss and potential birth defects if used among millions of overweight or obese Americans.

Although the FDA has yet to approve or ban the Vivus Qnexa drug, it has historically followed the advice of its advisors. As it can be imagined, shared in Vivus took a tumble as well as shared in rival Arena Pharmaceuticals Inc and Orexigen Therapeutics Inc.

The problem with anti obesity drugs is that they usually have radical effects on the body, and usually have secondary effects. Yes patients in trials have been known to lose weight dramatically, but at what cost?

The study also found that of some of the patients who did lose weight dramatically, many actually regained most of that weight once they stopped taking the drug. One patient said: “It’s like instant willpower,” said Erin Aycock, a clinical trial patient who lost 50 pounds on the drug but later regained most of it. “I would do anything to be back on this drug.”

We look forward to hearing the final decision from the FDA, as well as the outcome of the other two weight loss drugs.

Category : News

One Customer Review of “FDA Advisors Reject Qnexa Vivus Weight Loss Drug”

Review by [email protected], July 17, 2010

I’m personally glad they voted against this. The chemicals in this drug will do more harm than good long term. Just get eat right and exercise if you want to lose weight. It really is as simple as that. No studies or data has been release showing that this drug even worked to begin with.

Go fitness and do it naturally and you won’t regret it.

Write a Review of FDA Advisors Reject Qnexa Vivus Weight Loss Drug